|
XERS Xeris Biopharma Holdings Inc 1867096 |
| Balance Sheet |
|
Current Assets
|
167,662,000 |
|
Assets
|
323,060,000 |
|
Current Liabilities
|
100,443,000 |
|
Liabilities
|
352,675,000 |
|
Equity
|
-29,615,000 |
|
Shares Out
|
148,999,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-36,981,000 |
|
Investing Cash Flow
|
4,883,000 |
| Market Analysis |
Market Cap
|
452,956,346 |
|
Price
|
5.47 |
|
BVPS
|
3.59 |
|
PB
|
1.51 |
|
EPS
|
-0.42 |
|
PS
|
0.56 |
|
FCF
|
-32,098,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view XERS documents filed with the SEC.
XERS Filings
Clear
